Buy Aurobindo Pharma; target of Rs 850: Motilal Oswal News News / News 6 years ago 465 Views comments Motilal Oswal recommended buy rating on Aurobindo Pharma with a target price of Rs 850 in its research report dated July 19, 2017. Read more
Comments